JP2024505564A5 - - Google Patents
Info
- Publication number
- JP2024505564A5 JP2024505564A5 JP2023546449A JP2023546449A JP2024505564A5 JP 2024505564 A5 JP2024505564 A5 JP 2024505564A5 JP 2023546449 A JP2023546449 A JP 2023546449A JP 2023546449 A JP2023546449 A JP 2023546449A JP 2024505564 A5 JP2024505564 A5 JP 2024505564A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- modified immune
- immune cell
- cell according
- cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144860P | 2021-02-02 | 2021-02-02 | |
| US63/144,860 | 2021-02-02 | ||
| PCT/US2022/014936 WO2022169870A1 (en) | 2021-02-02 | 2022-02-02 | Self-polarizing immune cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505564A JP2024505564A (ja) | 2024-02-06 |
| JP2024505564A5 true JP2024505564A5 (https=) | 2025-01-27 |
Family
ID=82741763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546449A Pending JP2024505564A (ja) | 2021-02-02 | 2022-02-02 | 自己分極化免疫細胞 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240299543A1 (https=) |
| EP (1) | EP4288072A4 (https=) |
| JP (1) | JP2024505564A (https=) |
| KR (1) | KR20230141841A (https=) |
| CN (1) | CN116867501A (https=) |
| AU (1) | AU2022215561A1 (https=) |
| CA (1) | CA3206885A1 (https=) |
| IL (1) | IL304559A (https=) |
| MX (1) | MX2023008935A (https=) |
| WO (1) | WO2022169870A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121752592A (zh) * | 2023-05-12 | 2026-03-27 | 再生元制药公司 | 干扰素受体拮抗剂及其用途 |
| WO2025016399A1 (en) * | 2023-07-17 | 2025-01-23 | Nanjing Legend Biotech Co., Ltd. | Fusion proteins and methods of use thereof |
| WO2025235801A1 (en) | 2024-05-08 | 2025-11-13 | City Of Hope | Antibodies targeted to osteopontin and uses thereof for reducing resistance of solid tumors immune cell therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021505131A (ja) * | 2017-12-08 | 2021-02-18 | フェイト セラピューティクス，インコーポレイテッド | 増強されたｉＰＳＣ由来のエフェクター細胞を用いた免疫療法 |
| EP3561053A1 (en) * | 2018-04-26 | 2019-10-30 | Baylor College of Medicine | Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy |
| KR20210122814A (ko) * | 2019-02-01 | 2021-10-12 | 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 | 조작된 유전자 발현을 조절하기 위한 미세환경 센서 |
| CN114127297A (zh) * | 2019-03-26 | 2022-03-01 | 加维什-加利里生物应用有限公司 | 遗传重编程的表达car的treg |
-
2022
- 2022-02-02 EP EP22750324.0A patent/EP4288072A4/en active Pending
- 2022-02-02 CN CN202280012980.XA patent/CN116867501A/zh active Pending
- 2022-02-02 AU AU2022215561A patent/AU2022215561A1/en active Pending
- 2022-02-02 US US18/275,258 patent/US20240299543A1/en active Pending
- 2022-02-02 MX MX2023008935A patent/MX2023008935A/es unknown
- 2022-02-02 JP JP2023546449A patent/JP2024505564A/ja active Pending
- 2022-02-02 KR KR1020237029853A patent/KR20230141841A/ko active Pending
- 2022-02-02 CA CA3206885A patent/CA3206885A1/en active Pending
- 2022-02-02 WO PCT/US2022/014936 patent/WO2022169870A1/en not_active Ceased
-
2023
- 2023-07-18 IL IL304559A patent/IL304559A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024505564A5 (https=) | ||
| Cameron et al. | Cytokines, chemokines and their receptors | |
| US11339198B2 (en) | Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells | |
| Domingo-Gonzalez et al. | Cytokines and chemokines in Mycobacterium tuberculosis infection | |
| Morán et al. | Cytokines, chemokines and growth factors | |
| Hirano | Interleukin-6 and its relation to inflammation and disease | |
| Liu et al. | The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor | |
| Fischer et al. | A bioactive designer cytokine for human hematopoietic progenitor cell expansion | |
| Minty et al. | lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses | |
| JP6388408B2 (ja) | アゴニストおよびアンタゴニストとしての循環置換により修飾されるリガンド | |
| US6617135B1 (en) | Multiple cytokine protein complexes | |
| CN101484472B (zh) | 改善的sgp130Fc二聚体 | |
| US6423500B1 (en) | Mammalian receptors for interleukin-10 | |
| JP2021527700A5 (https=) | ||
| Fernandez-Botran | Soluble cytokine receptors: novel immunotherapeutic agents | |
| Shibuya et al. | Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes | |
| WO2022165443A1 (en) | Chimeric molecules comprising an il-10 or tgf-beta agonist polypeptide | |
| US7268223B2 (en) | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof | |
| CA3180251A1 (en) | Cytokine conjugates | |
| CN112839964A (zh) | 包含融合蛋白的药物组合物及其用途 | |
| JP2024515577A5 (https=) | ||
| Simbirtsev et al. | Cytokine system | |
| AU2013203171B2 (en) | Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells | |
| Lewko et al. | Cytokines | |
| Matthews | Cytokines, cytokine antagonists, and growth factors for treating infections |